- Home
- FE vs WST Comparison
FE vs WST Comparison
Compare FE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- WST
- Stock Information
- Founded
- FE 1996
- WST 1923
- Country
- FE United States
- WST United States
- Employees
- FE N/A
- WST N/A
- Industry
- FE Electric Utilities: Central
- WST Medical/Dental Instruments
- Sector
- FE Utilities
- WST Health Care
- Exchange
- FE Nasdaq
- WST Nasdaq
- Market Cap
- FE 24.5B
- WST 23.2B
- IPO Year
- FE N/A
- WST N/A
- Fundamental
- Price
- FE $42.39
- WST $322.75
- Analyst Decision
- FE Buy
- WST Buy
- Analyst Count
- FE 12
- WST 3
- Target Price
- FE $46.36
- WST $460.33
- AVG Volume (30 Days)
- FE 2.8M
- WST 587.4K
- Earning Date
- FE 10-29-2024
- WST 10-24-2024
- Dividend Yield
- FE 4.00%
- WST 0.26%
- EPS Growth
- FE 69.38
- WST N/A
- EPS
- FE 1.55
- WST 6.74
- Revenue
- FE $13,257,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- FE $13.65
- WST N/A
- Revenue Next Year
- FE $3.79
- WST $6.22
- P/E Ratio
- FE $27.45
- WST $48.32
- Revenue Growth
- FE 4.30
- WST N/A
- 52 Week Low
- FE $35.41
- WST $265.00
- 52 Week High
- FE $44.97
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- FE 54.62
- WST 53.83
- Support Level
- FE $41.73
- WST $315.17
- Resistance Level
- FE $42.87
- WST $326.58
- Average True Range (ATR)
- FE 0.53
- WST 9.63
- MACD
- FE 0.19
- WST -0.41
- Stochastic Oscillator
- FE 85.52
- WST 48.55
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.